Evidence-based coverage decisions? Primum non nocere

Health Affairs

Volumn 25, Issue 4, 2006, Pages

  McElwee, Newell E ^a,b   Ho, S Yin ^a,c   McGuigan, Kimberly A ^a,d   Horn, Mark L ^a,e  

^a PFIZER INC   (United States)

^b US Medical Group   (United States)

^c US Planning and Business Development Group   (United States)

^d US Outcomes Research   (United States)

^e Government Relations Group

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DECISION MAKING; DRUG USE; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PUBLICATION; REVIEW;

COST-BENEFIT ANALYSIS; DECISION MAKING; DRUG UTILIZATION REVIEW; EFFICIENCY, ORGANIZATIONAL; EVIDENCE-BASED MEDICINE; FORMULARIES; HEALTH CARE COALITIONS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES;

EID: 33746909081     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.25.w279     Document Type: Review

References (6)

1. P.J. Neumann, "Emerging Lessons from the Drug Effectiveness Review Project," Health Affairs 25 (2006): w262-w271 (published online 6 June 2006; 10.1377/hlthaff.25.w262).
2. S.B. Soumerai, "Benefits and Risks of Increasing Restrictions on Access to Costly Drugs in Medicaid," Health Affairs 23, no. 1 (2004): 135-146.
3. Because David Sackett was a co-editor on the first two editions of Evidence-based Medicine, and because he is known by many as the grandfather of EBM, we (and we think others) refer to the third edition as "Sackett's most recent text," even though he is not associated with this edition. S.E. Strauss et al., eds., Evidence-based Medicine: How to Practice and Teach EBM, 3d ed. (New York: Elsevier, 2005), 1.
4. D.L. Sackett et al., "Evidence Based Medicine: What It Is and What It Isn't," British Medical Journal 312, no. 7023 (1996): 71-72.
5. D.M. Eddy "Evidence-based Medicine: A Unified Approach," Health Affairs 24, no. 1 (2005): 9-17.
6. R.L. Kravitz, N. Duan, and J. Braslow, "Evidence-based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages," Milbank Quarterly 82, no. 4 (2004): 661-687.